Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2
{{output}}
In December 2022, the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became dominant in China due to its high infectivity and lower mortality rate. The risk of critical illness and mortality among patients with hematologic mali... ...
